Shuichi Sato Selected Research

Prostatic Neoplasms (Prostate Cancer)

11/2004	Inhibitory effects of a selective endothelin-A receptor antagonist YM598 on endothelin-1-induced potentiation of nociception in formalin-induced and prostate cancer-induced pain models in mice.
5/2004	Effects of selective endothelin ET(A) receptor antagonists on endothelin-1-induced potentiation of cancer pain.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shuichi Sato Research Topics

Disease

14	Neoplasms (Cancer) 03/2020 - 05/2004
11	Body Weight (Weight, Body) 01/2022 - 02/2008
10	Periodontitis 01/2022 - 12/2009
10	Cachexia 01/2019 - 01/2011
8	Infections 10/2020 - 02/2005
8	Hepatocellular Carcinoma (Hepatoma) 01/2020 - 02/2008
8	Overactive Urinary Bladder (Overactive Bladder) 11/2013 - 05/2004
5	Non-alcoholic Fatty Liver Disease 03/2021 - 01/2017
5	Fibrosis (Cirrhosis) 07/2020 - 01/2014
5	Inflammation (Inflammations) 01/2017 - 07/2013
5	Urinary Bladder Neck Obstruction (Bladder Neck Obstruction) 01/2013 - 03/2006
4	Pain (Aches) 01/2022 - 05/2004
4	Type 2 Diabetes Mellitus (MODY) 01/2022 - 12/2010
4	Periodontal Diseases (Periodontal Disease) 01/2019 - 04/2007
4	Liver Diseases (Liver Disease) 11/2017 - 01/2009
3	Pathologic Constriction (Stenosis) 12/2020 - 01/2018
3	Weight Loss (Weight Reduction) 12/2020 - 01/2011
3	Liver Cirrhosis (Hepatic Cirrhosis) 12/2020 - 06/2009
3	Disease Progression 03/2020 - 01/2014
3	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 06/2019 - 02/2008
3	Lower Urinary Tract Symptoms 01/2018 - 08/2004
3	Bone Resorption 12/2017 - 01/2017
3	Insulin Resistance 03/2015 - 04/2011
3	Chronic Hepatitis C 01/2010 - 02/2005
2	Gingival Fibromatosis 03/2022 - 07/2010
2	Edema (Dropsy) 12/2020 - 11/2004
2	Chronic Kidney Failure (Chronic Renal Failure) 07/2020 - 10/2010
2	Chronic Periodontitis 11/2019 - 08/2006
2	Osteoporosis 09/2018 - 03/2002
2	Chronic Hepatitis B 06/2018 - 01/2006
2	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 05/2018 - 08/2013
2	Wounds and Injuries (Trauma) 01/2018 - 07/2006
2	Necrosis 01/2018 - 03/2014
2	Squamous Cell Carcinoma of Head and Neck 01/2018 - 04/2016
2	Hyperalgesia 12/2017 - 01/2017
2	Hyperglycemia 01/2017 - 01/2013
2	Atrophy 04/2014 - 01/2014
2	Muscular Diseases (Myopathy) 03/2014 - 01/2014
2	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 03/2014 - 01/2014
2	Hypersensitivity (Allergy) 08/2013 - 04/2013
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2013 - 12/2010
2	Tooth Migration 07/2010 - 10/2004
2	Hepatitis C 06/2009 - 01/2006
2	Urge Urinary Incontinence (Urge Incontinence) 05/2007 - 01/2007
2	Gastroesophageal Reflux (GERD) 11/2006 - 02/2005
2	Prostatic Neoplasms (Prostate Cancer) 11/2004 - 05/2004

Drug/Important Bio-Agent (IBA)

9	Interleukin-6 (Interleukin 6)IBA 10/2020 - 01/2011
9	Proteins (Proteins, Gene)FDA Link 01/2019 - 02/2010
7	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 12/2010
7	Pharmaceutical PreparationsIBA 07/2020 - 03/2002
7	Muscle Proteins (Muscle Protein)IBA 01/2019 - 01/2011
6	Solifenacin Succinate FDA Link 01/2010 - 05/2004
5	CytokinesIBA 01/2022 - 07/2012
5	AcidsIBA 05/2018 - 11/2006
5	N- (6- methoxy- 5- (2- methoxyphenoxy)- 2- (pyrimidin- 2- yl)pyrimidin- 4- yl)- 2- phenylethenesulfonamide (YM598)IBA 02/2008 - 05/2004
5	Endothelins (Endothelin)IBA 02/2008 - 05/2004
4	InterleukinsIBA 10/2020 - 07/2012
4	mirabegronIBA 09/2017 - 01/2013
4	Tamsulosin (Flomax)FDA LinkGeneric 01/2010 - 08/2004
3	Ursodeoxycholic Acid (Urso)FDA LinkGeneric 02/2021 - 06/2009
3	Insulin-Like Growth Factor I (IGF-1)IBA 01/2020 - 01/2011
3	Proton Pump InhibitorsIBA 05/2018 - 02/2005
3	NF-kappa B (NF-kB)IBA 01/2017 - 03/2014
3	Messenger RNA (mRNA)IBA 05/2015 - 01/2011
3	Insulin (Novolin)FDA Link 03/2015 - 04/2011
3	DNA (Deoxyribonucleic Acid)IBA 04/2014 - 01/2006
3	Muscarinic AntagonistsIBA 01/2010 - 05/2004
3	Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA 12/2007 - 05/2004
2	Butyric Acid (Butanoic Acid)IBA 01/2022 - 07/2013
2	SodiumIBA 01/2022 - 12/2020
2	Blood Glucose (Blood Sugar)IBA 01/2022 - 12/2011
2	dapagliflozinIBA 03/2021 - 01/2017
2	Sodium-Glucose Transport ProteinsIBA 03/2021 - 07/2020
2	Sodium-Glucose Transporter 2 InhibitorsIBA 07/2020 - 01/2017
2	Triamcinolone Acetonide (Azmacort)FDA LinkGeneric 03/2020 - 01/2018
2	Biomarkers (Surrogate Marker)IBA 01/2020 - 06/2018
2	Interleukin-8 (Interleukin 8)IBA 11/2019 - 04/2016
2	salicylhydroxamic acid (SHAM)IBA 12/2017 - 05/2004
2	LipopolysaccharidesIBA 12/2017 - 01/2017
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2017 - 01/2014
2	Transcription Factors (Transcription Factor)IBA 04/2014 - 03/2014
2	DystrophinIBA 03/2014 - 01/2014
2	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 07/2012 - 01/2011
2	Durapatite (Hydroxylapatite)IBA 06/2012 - 12/2009
2	InterferonsIBA 01/2010 - 02/2005
2	Ribavirin (Virazole)FDA LinkGeneric 01/2010 - 01/2006
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2010 - 01/2009
2	Endothelin-1 (Endothelin 1)IBA 06/2006 - 05/2004
2	LipidsIBA 11/2005 - 02/2005
2	Famotidine (Pepcid)FDA LinkGeneric 02/2005 - 04/2003
2	AtrasentanIBA 11/2004 - 09/2004

Therapy/Procedure

16	Therapeutics 06/2019 - 10/2004
5	Liver Transplantation 07/2020 - 07/2008
5	Drug Therapy (Chemotherapy) 06/2019 - 01/2010
4	Ligation 12/2017 - 09/2006
3	Radiofrequency Ablation 01/2020 - 01/2009
3	Bite Force (Occlusal Forces) 10/2008 - 07/2006
2	Gingivectomy 03/2022 - 07/2010
2	Endoscopes 03/2020 - 01/2018
2	Oral Administration 06/2009 - 11/2004